Ying-hua Jin

Key Laboratory Of Geographical Processes And Ecological Security In Changbai Mountains
Changchun, 130024, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

A novel continuous-progression CKM model combined with multi-omics data integration identifies lipid metabolic drivers of disease progression.

A novel continuous-progression CKM model combined with multi-omics data integration identifies lipid metabolic drivers of disease progression.

Journal: Frontiers in endocrinology

Published: June 16, 2026

Li-ginseng powder alleviates cancer cachexia in mice by regulating the ubiquitin-proteasome pathway and reducing inflammation.

Li-ginseng powder alleviates cancer cachexia in mice by regulating the ubiquitin-proteasome pathway and reducing inflammation.

Journal: Journal of ginseng research

Published: February 13, 2026

Ginsenoside Rg5 Targets PRDX1 to Disrupt Redox Homeostasis and Induce Mitochondria-Dependent Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells.

Ginsenoside Rg5 Targets PRDX1 to Disrupt Redox Homeostasis and Induce Mitochondria-Dependent Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells.

Journal: Molecules (Basel, Switzerland)

Published: January 09, 2026

Li-Ginseng powder protects against alcohol-induced liver injury by promoting acetaldehyde clearance and cellular homeostasis.

Li-Ginseng powder protects against alcohol-induced liver injury by promoting acetaldehyde clearance and cellular homeostasis.

Journal: Journal of ginseng research

Published: July 02, 2025

The role of rare ginsenosides in the prevention and treatment of liver diseases.

The role of rare ginsenosides in the prevention and treatment of liver diseases.

Journal: Journal of ethnopharmacology

Published: March 30, 2025

Annexin A2 binds the 3'-UTR of H2AX mRNA and regulates histone-H2AX-derived hypoxia-inducible factor 1-alpha activation.

Annexin A2 binds the 3'-UTR of H2AX mRNA and regulates histone-H2AX-derived hypoxia-inducible factor 1-alpha activation.

Journal: Cellular signalling

Published: December 28, 2024

Integrative network pharmacology and experimental verification to reveal the anti-inflammatory mechanism of ginsenoside Rh4.

Integrative network pharmacology and experimental verification to reveal the anti-inflammatory mechanism of ginsenoside Rh4.

Journal: Frontiers in pharmacology

Published: May 26, 2022

(20S) Ginsenoside Rh2 Exerts Its Anti-Tumor Effect by Disrupting the HSP90A-Cdc37 System in Human Liver Cancer Cells.

(20S) Ginsenoside Rh2 Exerts Its Anti-Tumor Effect by Disrupting the HSP90A-Cdc37 System in Human Liver Cancer Cells.

Journal: International journal of molecular sciences

Published: November 11, 2021

(20S) Ginsenoside Rh2 Inhibits STAT3/VEGF Signaling by Targeting Annexin A2.

(20S) Ginsenoside Rh2 Inhibits STAT3/VEGF Signaling by Targeting Annexin A2.

Journal: International journal of molecular sciences

Published: July 04, 2021

The Anti-Tumor Effect and Underlying Apoptotic Mechanism of Ginsenoside Rk1 and Rg5 in Human Liver Cancer Cells.

The Anti-Tumor Effect and Underlying Apoptotic Mechanism of Ginsenoside Rk1 and Rg5 in Human Liver Cancer Cells.

Journal: Molecules (Basel, Switzerland)

Published: May 08, 2021

(20S)G-Rh2 Inhibits NF-κB Regulated Epithelial-Mesenchymal Transition by Targeting Annexin A2.

(20S)G-Rh2 Inhibits NF-κB Regulated Epithelial-Mesenchymal Transition by Targeting Annexin A2.

Journal: Biomolecules

Published: February 20, 2020

Specific Interaction With Human Serum Albumin Reduces Ginsenoside Cytotoxicity in Human Umbilical Vein Endothelial Cells.

Specific Interaction With Human Serum Albumin Reduces Ginsenoside Cytotoxicity in Human Umbilical Vein Endothelial Cells.

Journal: Frontiers in pharmacology

Published: November 28, 2019

Showing 1-12 of 30

Last Updated: 09/26/2026